{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:50:24Z","timestamp":1792824624925,"version":"4.5.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Tehran University of Medical Sciences","award":["95-02-41-32663"],"award-info":[{"award-number":["95-02-41-32663"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.gene.2019.03.033","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T10:39:46Z","timestamp":1553078386000},"page":"8-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":183,"special_numbering":"C","title":["Genetic implications in the pathogenesis of rheumatoid arthritis; an updated review"],"prefix":"10.1016","volume":"702","author":[{"given":"Jafar","family":"Karami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Aslani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmadreza","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Garshasbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8164-8831","authenticated-orcid":false,"given":"Mahdi","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2019.03.033_bb0005","first-page":"437","article-title":"Single nucleotide polymorphism rs 2476601 of PTPN22 gene and susceptibility to rheumatoid arthritis in Iranian population","volume":"14","author":"Ahmadloo","year":"2015","journal-title":"Iranian Journal of Allergy, Asthma and Immunology"},{"key":"10.1016\/j.gene.2019.03.033_bb0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.22631\/rr.2017.69997.1038","article-title":"Investigating the short-term impact of cognitive-behavioral therapy (CBT) on quality of life in Persian patients with rheumatoid arthritis: the heterogeneous impact on Arthritis Impact Measurement Scales (AIMS-2)","volume":"3","author":"Akhlaghi","year":"2018","journal-title":"Rheumatology Research"},{"key":"10.1016\/j.gene.2019.03.033_bb0015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.injr.2016.02.002","article-title":"STAT4 rs7574865 polymorphism in Iranian patients with rheumatoid arthritis","volume":"11","author":"Alizadeh","year":"2016","journal-title":"Indian J. Rheumatol."},{"key":"10.1016\/j.gene.2019.03.033_bb0020","first-page":"87","article-title":"Gene expression profiling of toll-like receptor 4 and 5 in peripheral blood mononuclear cells in rheumatic disorders: ankylosing spondylitis and rheumatoid arthritis","volume":"15","author":"Almasi","year":"2016","journal-title":"Iranian Journal of Allergy, Asthma and Immunology"},{"key":"10.1016\/j.gene.2019.03.033_bb0025","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/1756-185X.13126","article-title":"Histone variants expression in peripheral blood mononuclear cells of patients with rheumatoid arthritis","volume":"21","author":"Asadipour","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.gene.2019.03.033_bb0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/15513815.2016.1253809","article-title":"Lack of association between STAT4 single nucleotide polymorphisms and Iranian juvenile rheumatoid arthritis patients","volume":"36","author":"Aslani","year":"2017","journal-title":"Fetal and Pediatric Pathology"},{"key":"10.1016\/j.gene.2019.03.033_bb0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.22631\/rr.2018.69997.1041","article-title":"Genetic and epigenetic etiology of autoimmune diseases: lessons from twin studies","volume":"3","author":"Aslani","year":"2018","journal-title":"Rheumatology Research"},{"key":"10.1016\/j.gene.2019.03.033_bb0040","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00251-011-0528-6","article-title":"Genetics of rheumatoid arthritis: what have we learned?","volume":"63","author":"Bax","year":"2011","journal-title":"Immunogenetics"},{"key":"10.1016\/j.gene.2019.03.033_bb0045","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/ard.2003.016337","article-title":"Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene","volume":"63","author":"Berkun","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.gene.2019.03.033_bb0050","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jbspin.2011.05.018","article-title":"Associations of HLA-shared epitope, anti-citrullinated peptide antibodies and lifestyle-related factors in Hungarian patients with rheumatoid arthritis: data from the first Central-Eastern European cohort","volume":"78","author":"Besenyei","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.gene.2019.03.033_bb0055","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.22570","article-title":"Association of anti\u2013cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis","volume":"56","author":"Cha","year":"2007","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncprheum0072","article-title":"Pharmacogenetics in the rheumatic diseases, from pret-a-porter to haute couture","volume":"2","author":"Cronstein","year":"2006","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.gene.2019.03.033_bb0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrrheum.2011.28","article-title":"Rheumatoid arthritis: are ACPA-positive and ACPA-negative RA the same disease?","volume":"7","author":"Daha","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.gene.2019.03.033_bb0070","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/art.24503","article-title":"Confirmation of STAT4, IL2\/IL21, and CTLA4 polymorphisms in rheumatoid arthritis","volume":"60","author":"Daha","year":"2009","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0075","series-title":"Pharmacogenetics of Etanercept in Rheumatoid Arthritis","author":"Danila","year":"2008"},{"key":"10.1016\/j.gene.2019.03.033_bb0080","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/gene.2015.24","article-title":"The role of genetic variants in CRP in radiographic severity in African Americans with early and established rheumatoid arthritis","volume":"16","author":"Danila","year":"2015","journal-title":"Genes Immun."},{"key":"10.1016\/j.gene.2019.03.033_bb0085","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrrheum.2011.117","article-title":"Pharmacogenetics: implications for therapy in rheumatic diseases","volume":"7","author":"Davila","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.gene.2019.03.033_bb0090","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/annrheumdis-2012-202184","article-title":"Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis","volume":"72","author":"de Rooy","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.gene.2019.03.033_bb0095","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1136\/annrheumdis-2013-203375","article-title":"A genetic variant in the region of MMP-9 is associated with serum levels and progression of joint damage in rheumatoid arthritis","volume":"73","author":"de Rooy","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.gene.2019.03.033_bb0100","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3899\/jrheum.140741","article-title":"Genetic factors for the severity of ACPA-negative rheumatoid arthritis in 2 cohorts of early disease: a genome-wide study","volume":"42","author":"de Rooy","year":"2015","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.gene.2019.03.033_bb0105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/BOR.0b013e3283457524","article-title":"Genetics of rheumatoid arthritis: time for a change!","volume":"23","author":"de Vries","year":"2011","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.gene.2019.03.033_bb0110","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1399-0004.1989.tb03185.x","article-title":"The contribution of H LA to rheumatoid arthritis","volume":"36","author":"Deighton","year":"1989","journal-title":"Clin. Genet."},{"key":"10.1016\/j.gene.2019.03.033_bb0115","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00008571-200411000-00004","article-title":"Contribution of common polymorphisms in reduced folate carrier and \u03b3-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis","volume":"14","author":"Dervieux","year":"2004","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.gene.2019.03.033_bb0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/art.24135","article-title":"Different patterns of associations with anti\u2013citrullinated protein antibody\u2013positive and anti\u2013citrullinated protein antibody\u2013negative rheumatoid arthritis in the extended major histocompatibility complex region","volume":"60","author":"Ding","year":"2009","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0125","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/art.20989","article-title":"New classification of HLA\u2013DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility","volume":"52","author":"du Montcel","year":"2005","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0130","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.38308","article-title":"Contribution of functional LILRA3, but not nonfunctional LILRA3, to sex bias in susceptibility and severity of anti\u2013citrullinated protein antibody\u2013positive rheumatoid arthritis","volume":"66","author":"Du","year":"2014","journal-title":"Arthritis & rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.imlet.2017.11.004","article-title":"Survivin and autoimmunity; the ins and outs","volume":"193","author":"Ebrahimiyan","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.gene.2019.03.033_bb0140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/ard.2007.072819","article-title":"Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis","volume":"67","author":"Farag\u00f3","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.gene.2019.03.033_bb0145","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00296-008-0771-9","article-title":"Protein tyrosine phosphatase gene C1858T allele confers risk for rheumatoid arthritis in Hungarian subjects","volume":"29","author":"Farago","year":"2009","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.gene.2019.03.033_bb0150","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s13075-014-0436-x","article-title":"Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: case\u2013control study","volume":"16","author":"Ferreiro-Iglesias","year":"2014","journal-title":"Arthritis research & therapy"},{"key":"10.1016\/j.gene.2019.03.033_bb0155","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/rheumatology\/ken192","article-title":"Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis","volume":"47","author":"Go\u00ebb","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0160","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","article-title":"The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis","volume":"30","author":"Gregersen","year":"1987","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/rheumatology\/kep338","article-title":"New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies","volume":"49","author":"Gyetvai","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0170","first-page":"416","article-title":"CCR5 gene polymorphism is a genetic risk factor for radiographic severity of rheumatoid arthritis","volume":"80","author":"Han","year":"2012","journal-title":"HLA"},{"key":"10.1016\/j.gene.2019.03.033_bb0175","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.humimm.2012.02.011","article-title":"FCRL3 gene polymorphisms contribute to the radiographic severity rather than susceptibility of rheumatoid arthritis","volume":"73","author":"Han","year":"2012","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.gene.2019.03.033_bb0180","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.21385","article-title":"Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA\u2013DRB1 shared epitope for antibodies to citrullinated proteins","volume":"52","author":"Huizinga","year":"2005","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0185","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.cyto.2013.01.001","article-title":"Influence of interleukin-4 gene polymorphisms and interleukin-4 serum level on susceptibility and severity of rheumatoid arthritis in Egyptian population","volume":"61","author":"Hussein","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.gene.2019.03.033_bb0190","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/art.1780370511","article-title":"\u201cHomozygosity\u201d for the HLA\u2013DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins","volume":"37","author":"Jawaheer","year":"1994","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0195","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1136\/annrheumdis-2014-205539","article-title":"SPP1 rs9138 variant contributes to the severity of radiological damage in anti-citrullinated protein autoantibody-negative rheumatoid arthritis","volume":"73","author":"Juge","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.gene.2019.03.033_bb0200","first-page":"32","article-title":"Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis","volume":"10","author":"Kapit\u00e1ny","year":"2008","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.gene.2019.03.033_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.22631\/rr.2017.69997.1035","article-title":"A therapeutic role for potassium (K) to reduce pain and complications related to the cardiovascular system and bone in rheumatoid arthritis (RA): a clinical research perspective","volume":"3","author":"Kianifard","year":"2018","journal-title":"Rheumatology Research"},{"key":"10.1016\/j.gene.2019.03.033_bb0210","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/ncprheum0249","article-title":"Mechanisms of disease: genetic susceptibility and environmental triggers in the development of rheumatoid arthritis","volume":"2","author":"Klareskog","year":"2006","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.gene.2019.03.033_bb0215","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/BOR.0b013e32801127c8","article-title":"Smoking as a trigger for inflammatory rheumatic diseases","volume":"19","author":"Klareskog","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.gene.2019.03.033_bb0220","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1136\/annrheumdis-2012-201289","article-title":"Studying associations between variants in TRAF1-C5 and TNFAIP3-OLIG3 and the progression of joint destruction in rheumatoid arthritis in multiple cohorts","volume":"71","author":"Knevel","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.gene.2019.03.033_bb0225","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1136\/annrheumdis-2011-200724","article-title":"Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study","volume":"71","author":"Knevel","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.gene.2019.03.033_bb0230","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1136\/annrheumdis-2013-204050","article-title":"Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis","volume":"73","author":"Knevel","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.gene.2019.03.033_bb0235","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/art.37808","article-title":"A genetic variant in granzyme B is associated with progression of joint destruction in rheumatoid arthritis","volume":"65","author":"Knevel","year":"2013","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0240","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/ar4558","article-title":"A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis","volume":"16","author":"Knevel","year":"2014","journal-title":"Arthritis research & therapy"},{"key":"10.1016\/j.gene.2019.03.033_bb0245","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng.583","article-title":"A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility","volume":"42","author":"Kochi","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2019.03.033_bb0250","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1002\/art.38141","article-title":"Brief report: association of genetic variants in the IL4 and IL4R genes with the severity of joint damage in rheumatoid arthritis: a study in seven cohorts","volume":"65","author":"Krabben","year":"2013","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0255","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12016-012-8346-7","article-title":"Genetics of rheumatoid arthritis - a comprehensive review","volume":"45","author":"Kurko","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.gene.2019.03.033_bb0260","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1371\/journal.pmed.0040278","article-title":"A candidate gene approach identifies the TRAF1\/C5 region as a risk factor for rheumatoid arthritis","volume":"4","author":"Kurreeman","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.gene.2019.03.033_bb0265","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/art.34421","article-title":"Very high levels of anti\u2013citrullinated protein antibodies are associated with HLA\u2013DRB1* 15 non\u2013shared epitope allele in patients with rheumatoid arthritis","volume":"64","author":"Laki","year":"2012","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0270","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/art.22703","article-title":"Interaction between smoking, the shared epitope, and anti\u2013cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts","volume":"56","author":"Lee","year":"2007","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0275","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.3899\/jrheum.080186","article-title":"Associations between FCGR3A polymorphisms and susceptibility to rheumatoid arthritis: a metaanalysis","volume":"35","author":"Lee","year":"2008","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.gene.2019.03.033_bb0280","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cell.2013.08.034","article-title":"Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway","volume":"155","author":"Lee","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.gene.2019.03.033_bb0285","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/art.38343","article-title":"Increased Th17 cell frequency and poor clinical outcome in rheumatoid arthritis are associated with a genetic variant in the IL4R gene, rs1805010","volume":"66","author":"Leipe","year":"2014","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0290","doi-asserted-by":"crossref","first-page":"8873","DOI":"10.1007\/s11033-012-1754-1","article-title":"Association of STAT4 rs7574865 polymorphism with autoimmune diseases: a meta-analysis","volume":"39","author":"Liang","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.gene.2019.03.033_bb0295","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/03009740802256327","article-title":"Association of IRF5 gene polymorphisms with rheumatoid arthritis in a Tunisian population","volume":"37","author":"Maalej","year":"2008","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.gene.2019.03.033_bb0300","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/1756-185X.12999","article-title":"New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis","volume":"20","author":"Mahmoudi","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.gene.2019.03.033_bb0305","series-title":"Rheumatology Research","article-title":"mRNA expression evaluation of Drosha, Dicer, and DGCR8 in peripheral blood mononuclear cells of patients with rheumatoid arthritis","author":"Mahmoudi","year":"2018"},{"key":"10.1016\/j.gene.2019.03.033_bb0310","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10067-017-3968-z","article-title":"Single nucleotide polymorphism of methyl-CpG-binding protein 2 gene associates with juvenile idiopathic arthritis","volume":"37","author":"Mahmoudi","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.gene.2019.03.033_bb0315","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3899\/jrheum.120144","article-title":"Rheumatoid arthritis-associated polymorphisms at 6q23 are associated with radiological damage in autoantibody-positive RA","volume":"39","author":"Maxwell","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.gene.2019.03.033_bb0320","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3899\/jrheum.110961","article-title":"Peripheral blood gene expression and IgG glycosylation profiles as markers of tocilizumab treatment in rheumatoid arthritis","volume":"39","author":"Mesko","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.gene.2019.03.033_bb0325","doi-asserted-by":"crossref","first-page":"65","DOI":"10.22631\/rr.2017.69997.1020","article-title":"Cost comparison of illness in patients with rheumatoid arthritis, osteoarthritis and fibromyalgia syndrome","volume":"2","author":"Mobini","year":"2017","journal-title":"Rheumatology Research"},{"key":"10.1016\/j.gene.2019.03.033_bb0330","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cellimm.2011.11.005","article-title":"Influence of TRAF1\/C5 and STAT4 genes polymorphisms on susceptibility and severity of rheumatoid arthritis in Egyptian population","volume":"273","author":"Mohamed","year":"2012","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.gene.2019.03.033_bb0335","doi-asserted-by":"crossref","first-page":"35","DOI":"10.22631\/rr.2017.69997.1039","article-title":"Association study of CCR6 gene single nucleotide polymorphism with susceptibility to rheumatoid arthritis in Iranian population","volume":"3","author":"Mohammadi Kebar","year":"2018","journal-title":"Rheumatology Research"},{"key":"10.1016\/j.gene.2019.03.033_bb0340","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jcp.26911","article-title":"Implications of the noncoding RNAs in rheumatoid arthritis pathogenesis","volume":"234","author":"Mousavi","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.gene.2019.03.033_bb0345","doi-asserted-by":"crossref","first-page":"11618","DOI":"10.1073\/pnas.1501947112","article-title":"C5orf30 is a negative regulator of tissue damage in rheumatoid arthritis","volume":"112","author":"Muthana","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.gene.2019.03.033_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143757","article-title":"Association of killer cell immunoglobulin-like receptor genes in iranian patients with rheumatoid arthritis","volume":"10","author":"Nazari","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2019.03.033_bb0355","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1002\/art.20553","article-title":"A gene\u2013environment interaction between smoking and shared epitope genes in HLA\u2013DR provides a high risk of seropositive rheumatoid arthritis","volume":"50","author":"Padyukov","year":"2004","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0360","doi-asserted-by":"crossref","first-page":"496","DOI":"10.5414\/CPP42496","article-title":"The MDR1 3435 polymorphism in patients with rheumatoid arthritis","volume":"42","author":"Pawlik","year":"2004","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.gene.2019.03.033_bb0365","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1186\/ar2022","article-title":"Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides","volume":"8","author":"Pedersen","year":"2006","journal-title":"Arthritis research & therapy"},{"key":"10.1016\/j.gene.2019.03.033_bb0370","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa073491","article-title":"TRAF1\u2013C5 as a risk locus for rheumatoid arthritis\u2014a genomewide study","volume":"357","author":"Plenge","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gene.2019.03.033_bb0375","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1196\/annals.1423.004","article-title":"Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis","volume":"1110","author":"Poor","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.gene.2019.03.033_bb0380","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s13075-015-0830-z","article-title":"PTGER4 gene variant rs76523431 is a candidate risk factor for radiological joint damage in rheumatoid arthritis patients: a genetic study of six cohorts","volume":"17","author":"Rodriguez-Rodriguez","year":"2015","journal-title":"Arthritis research & therapy"},{"key":"10.1016\/j.gene.2019.03.033_bb0385","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/annrheumdis-2011-200337","article-title":"Fc\u03b3 receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab","volume":"71","author":"Ruyssen-Witrand","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.gene.2019.03.033_bb0390","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jbspin.2013.10.002","article-title":"Association of IL-2RA and IL-2RB genes with erosive status in early rheumatoid arthritis patients (ESPOIR and RMP cohorts)","volume":"81","author":"Ruyssen-Witrand","year":"2014","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.gene.2019.03.033_bb0395","doi-asserted-by":"crossref","first-page":"101","DOI":"10.22631\/rr.2018.69997.1049","article-title":"Evaluation of heart dysfunction in patients with rheumatoid arthritis","volume":"3","author":"Saadati","year":"2018","journal-title":"Rheumatology Research"},{"key":"10.1016\/j.gene.2019.03.033_bb0400","doi-asserted-by":"crossref","first-page":"61","DOI":"10.22631\/rr.2017.69997.1019","article-title":"Clinical manifestations and disease activity score of rheumatoid arthritis in southeast of Iran","volume":"2","author":"Sandoughi","year":"2017","journal-title":"Rheumatology Research"},{"key":"10.1016\/j.gene.2019.03.033_bb0405","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/ard.2008.106161","article-title":"Association of the 6q23 region with the rate of joint destruction in rheumatoid arthritis","volume":"69","author":"Scherer","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.gene.2019.03.033_bb0410","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.berh.2011.10.010","article-title":"Precipitating and perpetuating factors of rheumatoid arthritis immunopathology\u2013linking the triad of genetic predisposition, environmental risk factors and autoimmunity to disease pathogenesis","volume":"25","author":"Scott","year":"2011","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.gene.2019.03.033_bb0415","first-page":"338","article-title":"PADI4 polymorphisms in Iranian patients with rheumatoid arthritis","volume":"41","author":"Shamsian","year":"2016","journal-title":"Acta reumatologica portuguesa"},{"key":"10.1016\/j.gene.2019.03.033_bb0420","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/ard.2007.085704","article-title":"A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population","volume":"68","author":"Shimane","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.gene.2019.03.033_bb0425","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.gene.2019.03.033_bb0430","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/ng.582","article-title":"Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci","volume":"42","author":"Stahl","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2019.03.033_bb0435","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/art.38405","article-title":"Does a genetic variant in FOXO3A predict a milder course of rheumatoid arthritis?","volume":"66","author":"Steenbergen","year":"2014","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0440","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng1206","article-title":"Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis","volume":"34","author":"Suzuki","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2019.03.033_bb0445","article-title":"PADI4 and HLA-DRB1 are genetic risks for radiographic progression in RA patients, independent of ACPA status: results from the IORRA cohort study","volume":"8","author":"Suzuki","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2019.03.033_bb0450","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12016-007-8022-5","article-title":"Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets?","volume":"34","author":"Szekanecz","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.gene.2019.03.033_bb0455","first-page":"356","article-title":"Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases","volume":"69","author":"Szekanecz","year":"2011","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.gene.2019.03.033_bb0460","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.autrev.2009.04.006","article-title":"Anti-citrullinated protein\/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis","volume":"9","author":"Szodoray","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.gene.2019.03.033_bb0465","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1002\/art.38064","article-title":"Allele-dose association of the C5orf30 rs26232 variant with joint damage in rheumatoid arthritis","volume":"65","author":"Teare","year":"2013","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0470","series-title":"IL-1B and IL-1RN Gene Polymorphisms in Rheumatoid Arthritis: Relationship With Protein Plasma Levels and Response to Therapy","author":"Tolusso","year":"2006"},{"key":"10.1016\/j.gene.2019.03.033_bb0475","doi-asserted-by":"crossref","first-page":"R264","DOI":"10.1186\/ar4110","article-title":"Meta-analysis identified the TNFA-308G>A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritis","volume":"14","author":"Toonen","year":"2012","journal-title":"Arthritis research & therapy"},{"key":"10.1016\/j.gene.2019.03.033_bb0480","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.bor.0000160780.13012.be","article-title":"Understanding the genetic contribution to rheumatoid arthritis","volume":"17","author":"van der Helm","year":"2005","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.gene.2019.03.033_bb0485","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/art.22373","article-title":"The HLA\u2013DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide","volume":"56","author":"van der Helm-van Mil","year":"2007","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0490","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/art.24721","article-title":"Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis","volume":"60","author":"van der Linden","year":"2009","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0495","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.24385","article-title":"Quantitative heritability of anti\u2013citrullinated protein antibody\u2013positive and anti\u2013citrullinated protein antibody\u2013negative rheumatoid arthritis","volume":"60","author":"van der Woude","year":"2009","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0500","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/ng1010-814","article-title":"Gene-environment interaction influences the reactivity of autoantibodies to citrullinated antigens in rheumatoid arthritis","volume":"42","author":"van der Woude","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2019.03.033_bb0505","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/art.27366","volume":"62","author":"van der Woude","year":"2010","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0510","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/1529-0131(200111)44:11<2525::AID-ART432>3.0.CO;2-B","article-title":"The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients","volume":"44","author":"van Ede","year":"2001","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0515","series-title":"Switching Between Anti-tumour Necrosis Factors: Trying to Get a Handle on a Complex Issue","author":"van Vollenhoven","year":"2007"},{"key":"10.1016\/j.gene.2019.03.033_bb0520","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1002\/art.23127","article-title":"Fine specificity of the anti\u2013citrullinated protein antibody response is influenced by the shared epitope alleles","volume":"56","author":"Verpoort","year":"2007","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0525","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/art.39760","article-title":"Association between genetic variation in FOXO3 and reductions in inflammation and disease activity in inflammatory polyarthritis","volume":"68","author":"Viatte","year":"2016","journal-title":"Arthritis & Rheumatology"},{"key":"10.1016\/j.gene.2019.03.033_bb0530","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.berh.2008.09.011","article-title":"Smoking and inflammatory diseases","volume":"22","author":"Vittecoq","year":"2008","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.gene.2019.03.033_bb0535","first-page":"1","article-title":"Association of CD26\/dipeptidyl peptidase IV mRNA level in peripheral blood mononuclear cells with disease activity and bone erosion in rheumatoid arthritis","author":"Yeganeh","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.gene.2019.03.033_bb0540","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/annrheumdis-2013-203921","article-title":"Lack of association between IL-15 genetic variants and progression of joint destruction in Japanese patients with rheumatoid arthritis","volume":"73","author":"Yoshida","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.gene.2019.03.033_bb0545","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cellimm.2016.09.009","article-title":"PD-1\/PD-L and autoimmunity: a growing relationship","volume":"310","author":"Zamani","year":"2016","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.gene.2019.03.033_bb0550","first-page":"2299","article-title":"HLA-DR genotypes in familial rheumatoid arthritis: increased frequency of protective and neutral alleles in a multicase family","volume":"32","author":"Zsil\u00e1k","year":"2005","journal-title":"J. Rheumatol."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111919302902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111919302902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:22:30Z","timestamp":1759854150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111919302902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":110,"alternative-id":["S0378111919302902"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2019.03.033","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic implications in the pathogenesis of rheumatoid arthritis; an updated review","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2019.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}